CNO's cleanup is starting to show in earnings
- CNO is refocusing on core insurance after exiting a weak Worksite fee services business.
- Management reaffirmed 2026 operating EPS guidance of $4.25-$4.45 after Q1 operating EPS of $1.05.
- The Worksite fee services exit is expected to reduce annual fee revenue by about $30 million but raise annual pre-tax income by about $20 million.
- Health is the largest insurance line, with Q1 2026 product margin of $132.6 million.
- The main risks are investment losses, interest rate swings, and health claims that cost more than priced.
A cleaner insurance story
CNO's story has become simpler. The company is leaving the Worksite fee services business and putting more focus on health, annuity, and life insurance. That matters because management says the exit should cut annual fee revenue by about $30 million, but lift annual pre-tax income by about $20 million.
The latest proof point was Q1 2026. Net operating income rose to $101.3 million from $81.1 million a year earlier, and operating EPS was $1.05. Management also reaffirmed 2026 operating EPS guidance of $4.25-$4.45.
The bull case is about cleaner execution. If the Worksite exit finishes without surprise costs, CNO should have a more focused business and more cash to send to shareholders through buybacks. A possible shift from Medicare Advantage toward Medicare Supplement plans could also help the Health segment, which is already the largest insurance line.
The bear case is that this is still an insurer with long promises to policyholders. Investment markets, credit losses, interest rates, health care costs, and long-term care claims can all move against CNO. The Medicare Supplement tailwind may also fade if consumer behavior shifts back.
Premiums, claims, and investments
CNO makes money in three main ways. It collects premiums and tries to price policies so claims and expenses leave a profit. It earns investment income on the money it holds before paying claims. It also earns fees from services and from selling some third-party products.
The company targets middle-income Americans who are near retirement or already retired. Its reach comes from exclusive agents, independent producers, direct-to-consumer channels, phone, virtual, online, and face-to-face sales.
This model can work well when pricing is right and policyholders stay with the company. It can break when claims run hotter than expected, policyholders leave at bad times, or the investment portfolio loses value.
Products for older households
Health insurance
This is CNO's largest product line by Q1 2026 insurance product margin. It includes supplemental health, Medicare Supplement, and long-term care products.
Medicare Supplement
This product helps cover costs that original Medicare does not cover. Management noted a possible consumer shift away from Medicare Advantage and toward Medicare Supplement plans.
Long-term care
Long-term care can be profitable when claims and rate increases behave well. It is also one of the hardest products to price because claims can last for years.
Annuities
CNO mainly sells fixed indexed and fixed interest annuities. These products turn savings into more predictable income, but results are sensitive to interest rates and investment returns.
Life insurance
The Life line includes interest-sensitive life and traditional life products. It adds scale and steady margin, but depends on mortality, lapses, and investment spreads.
Third-party Medicare Advantage sales
The remaining Fee Income segment mainly comes from selling third-party Medicare Advantage products. Q1 2026 net fee income was $10.6 million.
Health leads the mix
The segment mix below uses Q1 2026 insurance product margin of $256.9 million. It excludes investment income not allocated to products and the remaining Fee Income segment.
What could go wrong
Claims cost more than priced
High impact · Medium oddsCNO's profit depends on mortality, morbidity, health care costs, and policyholder behavior. Long-term care is a special risk because claims can be large and long-lasting. If the company cannot get needed rate increases on time, margins can fall.
Investment portfolio stress
High impact · Medium oddsCNO holds a large investment portfolio to support future insurance claims. Credit losses, market volatility, or weaker capital markets can hurt earnings and capital. This risk can show up even when policy sales look fine.
Interest rates move against the model
Medium impact · Medium oddsInterest rates affect annuity spreads, investment income, policyholder behavior, and the value of assets. Fast rate moves can pressure cash flow and product profitability. The direction matters less than whether pricing and investments can adjust fast enough.
Worksite exit leaves trailing costs
Medium impact · Low oddsThe Worksite fee services exit looks mostly de-risked, but exits can leave contract costs, severance, systems costs, or legal obligations. CNO recorded a $1.9 million loss tied to the exit in Q1 2026 after a larger 2025 impairment and Q4 loss. More charges would weaken the clean-up story.
Medicare preference shift fades
Medium impact · Medium oddsManagement noted a possible shift from Medicare Advantage toward Medicare Supplement products. That could help CNO's Health segment if it lasts. If consumers move back toward Medicare Advantage, a possible growth tailwind would disappear.
In one breath
What does CNO Financial Group do?
CNO sells health, annuity, and life insurance products. Its main customers are middle-income Americans who are near retirement or already retired.
Why is CNO exiting the Worksite fee services business?
Management says the exit sharpens focus on the core insurance business. The company expects the move to reduce annual fee revenue by about $30 million but increase annual pre-tax income by about $20 million.
What is the most important CNO segment?
Health is the largest insurance product line by Q1 2026 product margin. It includes supplemental health, Medicare Supplement, and long-term care products.
What should investors watch next?
The key items are progress toward 2026 operating EPS guidance of $4.25-$4.45, a clean finish to the Worksite exit, and Medicare Supplement sales momentum. Investors should also watch investment losses and long-term care claims.